Goal

The goal of the CTSN is to foster a culture of rigorous scientific comparisons and to promote the evaluation of newer surgical techniques, devices, and innovative pharmaceutical and bioengineered products directed at improving cardiovascular disease outcomes in adult populations.

With support from the National Heart, Lung, and Blood Institute (NHLBI), the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH), and the Canadian Institutes of Health Research (CIHR), the CTSN provides the infrastructure to develop, coordinate, and conduct multiple collaborative proof-of-concept studies and interventional protocols to improve cardiovascular disease outcomes. Our network enables interdisciplinary research teams led to evaluate therapies and techniques as they move from laboratory s cience to broad clinical use.

News

New CTSN Funding Opportunity
The National Heart Lung and Blood Institute intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications from qualified institutions willing to participate with the NHLBI in the Cardiothoracic Surgical Trials Network (CTSN) as Linked Clinical Research Centers (LCRCs)
grants.nih.gov/grants/guide/notice-files/NOT-HL-18-606.html

Surgeon/Investigator Recruitment Opportunity
The Clinical Research Skills Development Core is recruiting. The CTSN offers a Clinical Research Skills Development Core program located at three network sites, The Cleveland Clinic Foundation led by Dr. Eugene Blackstone, Duke University led by Dr. Peter Smith, and the University of Virginia led by Dr. Gorav Ailawadi. Become certified in Clinical Research while meeting your clinical requirements! For more information about these programs, click here:   The Cleveland Clinic Program   The Duke Program   The UVA Program